Today (2014) eight of the top ten selling pharmaceuticals are protein based. Therefore the demand is growing for the sensitive and reliable quantification of these proteins or peptides in complex biological matrices such as plasma and serum to support (pre)-clinical research.
Currently ligand binding assays are the standard analytical technique to support (pre)-clinical research. However, there is a strong trend towards the use of liquid chromatography hyphenated with tandem mass spectrometry which offers a number of advantages.
Swiss Bioanalytics offers quantitation services for proteins and peptides in biological matrices under GLP. Upon request we are happy to provide you with detailed information about our validation procedures and workflows. Please see the links below for selected studies we have perfomed in this field.